Nitric oxide targets oligodendrocytes and promotes their morphological differentiation

GLIA

Volumn 63, Issue 3, 2015, Pages 383-399

  Garthwaite, Giti ^a   Hampden Smith, Kathryn ^a   Wilson, Gary W ^a   Goodwin, David A ^a   Garthwaite, John ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

Brainstem; Cerebellum; CGMP; Myelination; Natriuretic peptide; Optic nerve

Indexed keywords

ATRIAL NATRIURETIC FACTOR; CYCLIC GMP; GLUTAMATE RECEPTOR; GUANYLATE CYCLASE; ISOENZYME; NATRIURETIC FACTOR; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; 8-BROMOCYCLIC GMP; ENDOTHELIAL NITRIC OXIDE SYNTHASE; NEURONAL NITRIC OXIDE SYNTHASE; NOS1 PROTEIN, RAT; NOS3 PROTEIN, MOUSE; PROTEIN KINASE INHIBITOR;

ADULT; ANIMAL CELL; ANIMAL TISSUE; ARTICLE; BRAIN CELL CULTURE; BRAIN CORTEX; BRAIN DEVELOPMENT; BRAIN STEM; CELL DIFFERENTIATION; CELL GROWTH; CELL MATURATION; CELL STIMULATION; CELL STRUCTURE; CEREBELLUM; CONTROLLED STUDY; DEVELOPMENTAL STAGE; ENZYME ACTIVITY; FEMALE; IMMUNOCYTOCHEMISTRY; IMMUNOHISTOCHEMISTRY; MALE; MOUSE; NONHUMAN; OLIGODENDROGLIA; OPTIC NERVE; PHYSIOLOGICAL PROCESS; PRIORITY JOURNAL; RAT; SECOND MESSENGER; 129 MOUSE; ANALOGS AND DERIVATIVES; ANIMAL; BRAIN; C57BL MOUSE; CELL CULTURE; CYTOLOGY; GENETICS; GROWTH, DEVELOPMENT AND AGING; KNOCKOUT MOUSE; METABOLISM; PHYSIOLOGY; SPRAGUE DAWLEY RAT; TISSUE CULTURE TECHNIQUE;

ANIMALS; BRAIN; CELL DIFFERENTIATION; CELLS, CULTURED; CYCLIC GMP; MALE; MICE, 129 STRAIN; MICE, INBRED C57BL; MICE, KNOCKOUT; NATRIURETIC PEPTIDES; NITRIC OXIDE; NITRIC OXIDE SYNTHASE TYPE I; NITRIC OXIDE SYNTHASE TYPE III; OLIGODENDROGLIA; PROTEIN KINASE INHIBITORS; RATS, SPRAGUE-DAWLEY; TISSUE CULTURE TECHNIQUES;

EID: 84920962222     PISSN: 08941491     EISSN: 10981136     Source Type: Journal    
DOI: 10.1002/glia.22759     Document Type: Article

References (72)

1. Atkins CM, Sweatt JD. 1999. Reactive oxygen species mediate activity-dependent neuron-glia signaling in output fibers of the hippocampus. J Neurosci 19:7241-7248.
2. Azim K, Butt AM. 2011. GSK3beta negatively regulates oligodendrocyte differentiation and myelination in vivo. Glia 59:540-553.
3. Barbaresi P, Fabri M, Mensa E. 2014. Characterization of NO-producing neurons in the rat corpus callosum. Brain Behav 4:317-336.
4. Bartus K, Pigott B, Garthwaite J. 2013. Cellular targets of nitric oxide in the hippocampus. PLoS One 8:e57292.
5. Batchelor AM, Bartus K, Reynell C, Constantinou S, Halvey EJ, Held KF, Dostmann WR, Vernon J, Garthwaite J. 2010. Exquisite sensitivity to subsecond, picomolar nitric oxide transients conferred on cells by guanylyl cyclase-coupled receptors. Proc Natl Acad Sci USA 107:22060-22065.
6. Bellamy TC, Garthwaite J. 2001. "cAMP-specific" phosphodiesterase contributes to cGMP degradation in cerebellar cells exposed to nitric oxide. Mol Pharmacol 59:54-61.
7. Bolte S, Cordelieres FP. 2006. A guided tour into subcellular colocalization analysis in light microscopy. J Microsc 224:213-232.
8. Bredt DS, Hwang PM, Snyder SH. 1990. Localization of nitric oxide synthase indicating a neural role for nitric oxide. Nature 347:768-770.
9. Cao LH, Yang XL. 2008. Natriuretic peptides and their receptors in the central nervous system. Prog Neurobiol 84:234-248.
10. Chakraborty G, Ledeen RW. 1993. Guanylyl cyclase activity in rat brain myelin and white matter. J Neurochem 61:1953-1956.
11. Chen B, Deen WM. 2001. Analysis of the effects of cell spacing and liquid depth on nitric oxide and its oxidation products in cell cultures. Chem Res Toxicol 14:135-147.
12. Cho HJ, Xie QW, Calaycay J, Mumford RA, Swiderek KM, Lee TD, Nathan C. 1992. Calmodulin is a subunit of nitric oxide synthase from macrophages. J Exp Med 176:599-604.
13. Contestabile A. 2012. Role of nitric oxide in cerebellar development and function: Focus on granule neurons. Cerebellum 11:50-61.
14. de Vente J, Asan E, Gambaryan S, Markerink-van IM, Axer H, Gallatz K, Lohmann SM, Palkovits M. 2001. Localization of cGMP-dependent protein kinase type II in rat brain. Neuroscience 108:27-49.
15. de Vente J, Bol JGJM, Berkelmans HS, Schipper J, Steinbusch HW. 1990. Immunocytochemistry of cGMP in the cerebellum of the immature, adult, and aged rat: The involvement of nitric oxide. A micropharmacological study. Eur J Neurosci 2:845-862.
16. Demas GE, Kriegsfeld LJ, Blackshaw S, Huang P, Gammie SC, Nelson RJ, Snyder SH. 1999. Elimination of aggressive behavior in male mice lacking endothelial nitric oxide synthase. J Neurosci 19:RC30.
17. Ding JD, Burette A, Nedvetsky PI, Schmidt HH, Weinberg RJ. 2004. Distribution of soluble guanylyl cyclase in the rat brain. J Comp Neurol 472:437-448.
18. Downing AL, Truesdale GA. 1955. Some factors affecting the rate of solution of oxygen in water. J Appl Chem 5:570-581.
19. Emery B. 2010. Regulation of oligodendrocyte differentiation and myelination. Science 330:779-782.
20. Evgenov OV, Pacher P, Schmidt PM, Hasko G, Schmidt HH, Stasch JP. 2006. NO-independent stimulators and activators of soluble guanylate cyclase: Discovery and therapeutic potential. Nat Rev Drug Discov 5:755-768.
21. Ferrendelli JA, Chang MM, Kinscherf DA. 1974. Elevation of cyclic GMP levels in central nervous system by excitatory and inhibitory amino acids. J Neurochem 22:535-540.
22. Fulton D, Gratton JP, Sessa WC. 2001. Post-translational control of endothelial nitric oxide synthase: Why isn't calcium/calmodulin enough? J Pharmacol Exp Ther 299:818-824.
23. Furuyama T, Inagaki S, Takagi H. 1993. Localizations of alpha 1 and beta 1 subunits of soluble guanylate cyclase in the rat brain. Brain Res Mol Brain Res 20:335-344.
24. Garthwaite G, Bartus K, Malcolm D, Goodwin DA, Kollb-Sielecka M, Dooldeniya C, Garthwaite J. 2006. Signaling from blood vessels to CNS axons through nitric oxide. J Neurosci 26:7730-7740.
25. Garthwaite G, Goodwin DA, Garthwaite J. 1999. Nitric oxide stimulates cGMP formation in rat optic nerve axons, providing a specific marker of axon viability. Eur J Neurosci 11:4367-4372.
26. Garthwaite J. 1985. Cellular uptake disguises action of L-glutamate on N-methyl-D- aspartate receptors. With an appendix: Diffusion of transported amino acids into brain slices. Br J Pharmacol 85:297-307.
27. Garthwaite J. 2008. Concepts of neural nitric oxide-mediated transmission. Eur J Neurosci 27:2783-2802.
28. Garthwaite J, Southam E, Boulton CL, Nielsen EB, Schmidt K, Mayer B. 1995. Potent and selective inhibition of nitric oxide-sensitive guanylyl cyclase by 1H-[1, 2, 4]oxadiazolo[4, 3-a]quinoxalin-1-one. Mol Pharmacol 48:184-188.
29. Gianola S, Savio T, Schwab ME, Rossi F. 2003. Cell-autonomous mechanisms and myelin-associated factors contribute to the development of Purkinje axon intracortical plexus in the rat cerebellum. J Neurosci 23:4613-4624.
30. Gibb BJ, Garthwaite J. 2001. Subunits of the nitric oxide receptor, soluble guanylyl cyclase, expressed in rat brain. Eur J Neurosci 13:539-544.
31. Gibson EM, Purger D, Mount CW, Goldstein AK, Lin GL, Wood LS, Inema I, Miller SE, Bieri G, Zuchero JB, Barres BA, Woo PJ, Vogel H, Monje M. 2014. Neuronal activity promotes oligodendrogenesis and adaptive myelination in the mammalian brain. Science 344:1252304.
32. Griffiths C, Garthwaite J. 2001. The shaping of nitric oxide signals by a cellular sink. J Physiol (Lond) 536:855-862.
33. Gudi T, Hong GK, Vaandrager AB, Lohmann SM, Pilz RB. 1999. Nitric oxide and cGMP regulate gene expression in neuronal and glial cells by activating type II cGMP-dependent protein kinase. Faseb J 13:2143-2152.
34. Hall CN, Garthwaite J. 2009. What is the real physiological NO concentration in vivo? Nitric Oxide 21:92-103.
35. Haramis G, Zhou Z, Pyriochou A, Koutsilieris M, Roussos C, Papapetropoulos A. 2008. cGMP-independent anti-tumour actions of the inhibitor of soluble guanylyl cyclase, ODQ, in prostate cancer cell lines. Br J Pharmacol 155:804-813.
36. Hardingham N, Dachtler J, Fox K. 2013. The role of nitric oxide in pre-synaptic plasticity and homeostasis. Front Cell Neurosci 7:190.
37. Hernandez F, Alexander SP, Kendall DA. 1994. Natriuretic peptide-induced cyclic GMP accumulation in adult guinea-pig cerebellar slices. Br J Pharmacol 113:216-220.
38. Hopper RA, Garthwaite J. 2006. Tonic and phasic nitric oxide signals in hippocampal long-term potentiation. J Neurosci 26:11513-11521.
39. Kawasaki Y, Kugimiya F, Chikuda H, Kamekura S, Ikeda T, Kawamura N, Saito T, Shinoda Y, Higashikawa A, Yano F, Ogasawara T, Ogata N, Hoshi K, Hofmann F, Woodgett JR, Nakamura K, Chung UI, Kawaguchi H. 2008. Phosphorylation of GSK-3beta by cGMP-dependent protein kinase II promotes hypertrophic differentiation of murine chondrocytes. J Clin Invest 118:2506-2515.
40. Kawata M, Nakao K, Morii N, Kiso Y, Yamashita H, Imura H, Sano Y. 1985. Atrial natriuretic polypeptide: Topographical distribution in the rat brain by radioimmunoassay and immunohistochemistry. Neuroscience 16:521-546.
41. Keilhoff G, Seidel B, Wolf G. 1998. Absence of nitric oxide synthase in rat oligodendrocytes: A light and electron microscopic study. Acta Histochem 100:409-417.
42. Kessaris N, Jamen F, Rubin LL, Richardson WD. 2004. Cooperation between sonic hedgehog and fibroblast growth factor/MAPK signalling pathways in neocortical precursors. Development 131:1289-1298.
43. Kingston AE, Ornstein PL, Wright RA, Johnson BG, Mayne NG, Burnett JP, Belagaje R, Wu S, Schoepp DD. 1998. LY341495 is a nanomolar potent and selective antagonist of group II metabotropic glutamate receptors. Neuropharmacology 37:1-12.
44. Lassmann H. 2011. Mechanisms of neurodegeneration shared between multiple sclerosis and Alzheimer's disease. J Neural Transm 118:747-752.
45. Linares D, Taconis M, Mana P, Correcha M, Fordham S, Staykova M, Willenborg DO. 2006. Neuronal nitric oxide synthase plays a key role in CNS demyelination. J Neurosci 26:12672-12681.
46. Makoukji J, Belle M, Meffre D, Stassart R, Grenier J, Shackleford G, Fledrich R, Fonte C, Branchu J, Goulard M, de WC, Charbonnier F, Sereda MW, Baulieu EE, Schumacher M, Bernard S, Massaad C. 2012. Lithium enhances remyelination of peripheral nerves. Proc Natl Acad Sci USA 109:3973-3978.
47. Mooradian DL, Hutsell TC, Keefer LK. 1995. Nitric oxide (NO) donor molecules: Effect of NO release rate on vascular smooth muscle cell proliferation in vitro. J Cardiovasc Pharmacol 25:674-678.
48. Moriyoshi K, Masu M, Ishii T, Shigemoto R, Mizuno N, Nakanishi S. 1991. Molecular cloning and characterization of the rat NMDA receptor. Nature 354:31-37.
49. Niu J, Mei F, Wang L, Liu S, Tian Y, Mo W, Li H, Lu QR, Xiao L. 2012. Phosphorylated olig1 localizes to the cytosol of oligodendrocytes and promotes membrane expansion and maturation. Glia 60:1427-1436.
50. Ogata T, Iijima S, Hoshikawa S, Miura T, Yamamoto S, Oda H, Nakamura K, Tanaka S. 2004. Opposing extracellular signal-regulated kinase and Akt pathways control Schwann cell myelination. J Neurosci 24:6724-6732.
51. Olivier P, Loron G, Fontaine RH, Pansiot J, Dalous J, Thi HP, Charriaut-Marlangue C, Thomas JL, Mercier JC, Gressens P, Baud O. 2010. Nitric oxide plays a key role in myelination in the developing brain. J Neuropathol Exp Neurol 69:828-837.
52. Pigott B, Bartus K, Garthwaite J. 2013. On the selectivity of neuronal NOS inhibitors. Br J Pharmacol 168:1255-1265.
53. Pohler D, Butt E, Meissner J, Muller S, Lohse M, Walter U, Lohmann SM, Jarchau T. 1995. Expression, purification, and characterization of the cGMP-dependent protein kinases I beta and II using the baculovirus system. FEBS Lett 374:419-425.
54. Reynolds R, Wilkin GP. 1988. Development of macroglial cells in rat cerebellum. II. An in situ immunohistochemical study of oligodendroglial lineage from precursor to mature myelinating cell. Development 102:409-425.
55. Rockland KS, Nayyar N. 2012. Association of type I neurons positive for NADPH-diaphorase with blood vessels in the adult monkey corpus callosum. Front Neural Circuits 6:4.
56. Roy B, Halvey EJ, Garthwaite J. 2008. An enzyme-linked receptor mechanism for nitric oxide-activated guanylyl cyclase. J Biol Chem 283:18841-18851.
57. Schmidt K, Desch W, Klatt P, Kukovetz WR, Mayer B. 1997. Release of nitric oxide from donors with known half-life: A mathematical model for calculating nitric oxide concentrations in aerobic solutions. Naunyn Schmiedebergs Arch Pharmacol 355:457-462.
58. Smith KJ, Lassmann H. 2002. The role of nitric oxide in multiple sclerosis. Lancet Neurol 1:232-241.
59. Son H, Hawkins RD, Martin K, Kiebler M, Huang PL, Fishman MC, Kandel ER. 1996. Long-term potentiation is reduced in mice that are doubly mutant in endothelial and neuronal nitric oxide synthase. Cell 87:1015-1023.
60. Southam E, East SJ, Garthwaite J. 1991. Excitatory amino acid receptors coupled to the nitric oxide/cyclic GMP pathway in rat cerebellum during development. J Neurochem 56:2072-2081.
61. Southam E, Morris R, Garthwaite J. 1992. Sources and targets of nitric oxide in rat cerebellum. Neurosci Lett 137:241-244.
62. Steinert JR, Chernova T, Forsythe ID. 2010. Nitric oxide signaling in brain function, dysfunction, and dementia. Neuroscientist 16:435-452.
63. Stevens B, Porta S, Haak LL, Gallo V, Fields RD. 2002. Adenosine: A neuron-glial transmitter promoting myelination in the CNS in response to action potentials. Neuron 36:855-868.
64. Tanaka J, Markerink van Ittersum M, Steinbusch HW, de Vente J. 1997. Nitric oxide-mediated cGMP synthesis in oligodendrocytes in the developing rat brain. Glia 19:286-297.
65. Tekki-Kessaris N, Woodruff R, Hall AC, Gaffield W, Kimura S, Stiles CD, Rowitch DH, Richardson WD. 2001. Hedgehog-dependent oligodendrocyte lineage specification in the telencephalon. Development 128:2545-2554.
66. Teunissen CE, Steinbusch HW, Markerink-Van Ittersum M, de Bruijn C, Axer H, de Vente J. 2000. Whole brain spheroid cultures as a model to study the development of nitric oxide synthase-guanylate cyclase signal transduction. Brain Res Dev Brain Res 125:99-115.
67. Wilson RI, Godecke A, Brown RE, Schrader J, Haas HL. 1999. Mice deficient in endothelial nitric oxide synthase exhibit a selective deficit in hippocampal long-term potentiation. Neuroscience 90:1157-1165.
68. Wood KC, Batchelor AM, Bartus K, Harris KL, Garthwaite G, Vernon J, Garthwaite J. 2011. Picomolar nitric oxide signals from central neurons recorded using ultrasensitive detector cells. J Biol Chem 286:43172-43181.
69. Yang G, Zhang Y, Ross ME, Iadecola C. 2003. Attenuation of activity-induced increases in cerebellar blood flow in mice lacking neuronal nitric oxide synthase. Am J Physiol Heart Circ Physiol 285:H298-H304.
70. Yoshioka A, Yamaya Y, Saiki S, Kanemoto M, Hirose G, Pleasure D. 2000. Cyclic GMP/cyclic GMP-dependent protein kinase system prevents excitotoxicity in an immortalized oligodendroglial cell line. J Neurochem 74:633-640.
71. Young KM, Psachoulia K, Tripathi RB, Dunn SJ, Cossell L, Attwell D, Tohyama K, Richardson WD. 2013. Oligodendrocyte dynamics in the healthy adult CNS: Evidence for myelin remodeling. Neuron 77:873-885.
72. Zuchero JB, Barres BA. 2013. Intrinsic and extrinsic control of oligodendrocyte development. Curr Opin Neurobiol 23:914-920.